Does Structured Reporting Improve Lung Cancer Reports?
-
By
-
Andrea Surnit
-
July 2, 2026
-
3 min
By
Andrea Surnit
July 2, 2026
A combination of PSA density, MRI, and PSMA PET findings identified a small subgroup with adverse pathology, supporting further study of biopsy-sparing pathways.
September 8, 2026
Investigators compared intra-articular microbial profiles and predicted metabolic pathways in patients with hip osteoarthritis and nonarthritic controls.
September 4, 2026
The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.
August 10, 2026